Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
Heart implant offers Blood-Thinner alternative for stroke prevention
Disease control OngoingThis early study is testing a small heart implant called the Laminar Left Atrial Appendage Closure System. It's designed for people with atrial fibrillation who cannot take long-term blood thinners but still need stroke prevention. The device is placed in the heart to seal off an…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Heart implant trial aims to block stroke risk without lifelong blood thinners
Disease control TerminatedThis study is testing a new heart implant device designed to seal off a small pouch in the heart where blood clots often form in people with atrial fibrillation. The goal is to prevent strokes and other blood clots without requiring patients to take lifelong blood-thinning medica…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New heart procedure tested for Long-Term control of irregular heartbeat
Disease control OngoingThis study is testing a specialized catheter (THERMOCOOL SMARTTOUCH®SF) guided by a measurement called Ablation Index for treating paroxysmal atrial fibrillation (a type of irregular heartbeat). It aims to see how well this procedure controls the irregular heartbeat and how safe …
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC